ASX-Dividend-Report-Banner

Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
What Do Andean Precious Metals' 2024 Financials Reveal?
Metal & Mining Stocks

What Do Andean Precious Metals' 2024 Financials Reveal?

Highlights,Revenue experienced a dramatic increase compared to the prior fiscal period.,Net income underwent a substantial decrease, leading to a notably lower profit margin.,The stock observed a moderate appreciation over the past week.,Andean Precious M...

Will Quebecor Excel in Telecom Financial Performance?
Communication Stocks

Will Quebecor Excel in Telecom Financial Performance?

Highlights:,Quebecor Inc. (TSX:QBR.A) achieves a return on capital employed above industry figures.,Consistent capital reinvestment observed across recent fiscal periods.,A robust dividend program reinforces steady financial performance.,Quebecor Inc. (TS...

Who Holds the Key Shares of Newcore Gold?
Metal & Mining Stocks

Who Holds the Key Shares of Newcore Gold?

Highlights,Individual investors command the majority of shares.,Institutions maintain a noteworthy portion of the ownership structure.,Company leadership has recently increased their share acquisition.,Newcore Gold Ltd. (TSXV:NCAU) operates within the pre...

Is This Dividend Payment Stable Enough?
Dividend Stocks

Is This Dividend Payment Stable Enough?

Highlights:,Dividend yield surpasses average figures in the manufacturing and distribution field,Company’s payout ratio stands at an elevated level,Earnings per share growth recorded over several periods,Decisive Dividend (TSXV:DE) operates within the man...

Is Crescita Therapeutics Shifting Its Fiscal Trajectory in the Biopharma Sector?
Healthcare Stocks

Is Crescita Therapeutics Shifting Its Fiscal Trajectory in the Biopharma Sector?

Highlights,A marked increase in revenue was observed in the recent fiscal period.,The company experienced a significant expansion in its net loss compared to the prior year.,Recent trading sessions registered a modest rise in share price over the past wee...

Is GFL Environmental Facing Financial Pressure Amid Rising Debt?
Industrial Stocks

Is GFL Environmental Facing Financial Pressure Amid Rising Debt?

Highlights:,GFL Environmental Inc. (TSX:GFL) reports increased debt levels.,Financial leverage evident from current interest coverage ratios.,The company shows steady earnings growth, reinforcing its financial stability.,GFL Environmental Inc. (TSX:GFL) o...

Is Crescita Therapeutics Shifting Its Fiscal Trajectory in the Biopharma Sector?
Healthcare Stocks

Is Crescita Therapeutics Shifting Its Fiscal Trajectory in the Biopharma Sector?

Highlights,A marked increase in revenue was observed in the recent fiscal period.,The company experienced a significant expansion in its net loss compared to the prior year.,Recent trading sessions registered a modest rise in share price over the past wee...

Does Elemental Altus Royalties' Elevated P/S Ratio Reflect Underlying Market Trends?
Metal & Mining Stocks

Does Elemental Altus Royalties' Elevated P/S Ratio Reflect Underlying Market Trends?

Highlights,Elemental Altus Royalties Corp. (TSXV:ELE) trades at an unusually high price-to-sales ratio compared to peers.,A significant gap exists between current revenue growth and forthcoming business outlook.,Elevated valuation metrics contrast with ma...

Are Journey Energy's Earnings Facing Hidden Challenges?
Energy Stocks

Are Journey Energy's Earnings Facing Hidden Challenges?

Highlights,Share dilution impacts earnings per share.,Unusual items affect reported profit figures.,Share issuance alters shareholder value metrics.,Journey Energy Inc. (TSX:JOY) operates in the energy exploration and production sector, an area characteri...

Can Cipher Pharmaceuticals Sustain Its Revenue Growth?
Healthcare Stocks

Can Cipher Pharmaceuticals Sustain Its Revenue Growth?

Highlights:,Revenue climbed significantly, reaching US$33.4m with an increase of 58%.,Net income decreased by 43% amid elevated operational expenses.,Forward revenue growth rate is set to exceed that of the Canadian pharmaceuticals sector.,Cipher Pharmace...

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.